Human immunoglobulin (Harbin Pacific Biopharmaceutical)

人免疫球蛋白 (哈尔滨派斯菲科生物)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (Harbin Pacific Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHepatitisMeasles
Global Approved IndicationsHepatitisMeasles
Approved Indications in ChinaHepatitisMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitisMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A